Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The Purpose of the study is to determine the effects of Androxal on morning testosterone and
reproductive status in men with secondary hypogonadism(confirmed morning Testosterone less
than 250 ng/dL), compared to changes with placebo, or Testim (topical testosterone). The
effects of Testim versus placebo on reproductive status will also be examined. Study subjects
must not be currently using a topical testosterone.